Adma Biologics reported $2.09B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Novavax USD 1.09B 316M Dec/2025
Takeda JPY 9.01T 1.37T Mar/2026